Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.9 DKK | +1.65% |
|
0.00% | -1.85% |
26/06 | Otsuka and Lundbeck's PTSD Treatment Moves Forward as FDA Accepts New Drug Application | MT |
25/06 | US FDA Accepts Lundbeck, Otsuka's New Drug Application for PTSD Combo Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.85% | 535.53Cr | |
+25.62% | 7.61TCr | |
-4.59% | 2.38TCr | |
+15.24% | 880.49Cr | |
+1.71% | 828.85Cr | |
-32.22% | 676.62Cr | |
+1.44% | 405.73Cr | |
-9.44% | 377.01Cr | |
-9.28% | 338.56Cr | |
+8.56% | 327.51Cr |
- Stock Market
- Equities
- HLUN B Stock
- LUN Stock
- News Lundbeck
- Transcript : H. Lundbeck A/S, Q2 2023 Earnings Call, Aug 16, 2023